据了解，该工程项目占地面积约21.45亩，建筑包含地上与地下部分。设计将延续浙大邵逸夫医院 建筑贯通特色，通过连廊与钱塘院区医疗综合楼相连。 质子治疗中心将配套国际先进的360°旋转束质子治疗系统及相关医疗功能区域，包含直加治疗区 （内设直线加速器、CT、MR、PET等先进定位设备）、日间化疗中心及门诊等用房，可为患者提供以 质子治疗为核心的全程化、便捷化、精准化"一站式"诊疗服务，通过优化流程缩短住院时间，最大程度 提升患者就医体验。其中，质子治疗系统采用加速器与治疗室分隔的分体式布局，相较于单机一体式结 构，具有辐射影响小、束流品质高等鲜明优势。 科研转化大楼将配套建设以质子治疗与研究为特色的肿瘤防治技术创新与临床转化平台，并提供系 统化的教学课程与实操训练，助力质子治疗领域专业人才培养，形成科研、教学与临床相互促进的良性 发展格局。 浙江大学医学院附属邵逸夫医院（以下简称"浙大邵逸夫医院"）质子治疗中心暨科研转化大楼工程 项目日前在钱塘院区正式开工，标志着浙江省在质子治疗领域迈出了实质性、关键性的一步。该项目预 计将于2028年10月交付投用。 质子治疗是国际公认的尖端放射治疗技术，能够精准靶向治疗恶性 ...

该质子治疗中心将配套国际先进的360°旋转束质子治疗系统及相关医疗功能区域，包含直加治疗区（内 设直线加速器、CT、MR、PET等先进定位设备）、日间化疗中心及门诊等用房，旨在为患者提供以质 子治疗为核心的全程化、便捷化、精准化"一站式"诊疗服务，通过优化流程缩短住院时间，最大程度提 升患者就医体验。这套质子治疗系统采用加速器与治疗室分隔的分体式布局，相较于单机一体式结构， 具有辐射影响小、束流品质高等鲜明优势。 商报讯（记者 王然 通讯员 李文芳 张冰清）昨日，浙江大学医学院附属邵逸夫医院（以下简称"浙大邵 逸夫医院"）质子治疗中心暨科研转化大楼工程项目开工仪式在钱塘院区举行，标志着浙江省在质子治 疗领域迈出了实质性、关键性的一步。 据了解，质子治疗是国际公认的尖端放射治疗技术，能够精准靶向治疗恶性肿瘤，相较于传统放疗，可 更有效地保护周围正常组织，尤其适用于紧贴脑干、脊髓、视神经、心脏或儿童重要生长中枢的肿瘤治 疗。我国肿瘤患者基数庞大，每年新增需放疗的癌症患者约百万例，对多样化、高品质的医疗技术的需 求日益迫切。目前，全球质子治疗中心超百家，我国正持续加大在这一领域的投入力量，以期让更多患 者获益。 浙 ...

Core Insights - The Hefei Ion Medical Center has seen a continuous increase in proton therapy patients since its opening, with the second proton therapy ward officially launched on January 8, significantly enhancing inpatient treatment capacity [1] - Proton therapy is recognized as an advanced international cancer radiation treatment technology that targets tumors with higher precision, reducing damage to surrounding healthy tissues [1] - The center has treated over 600 cancer patients with proton therapy since its inception, and the new ward will double the number of inpatient beds from 44 to 94, alleviating treatment wait times [1] Group 1 - The second proton therapy ward will greatly relieve treatment waiting pressure and provide high-standard precision radiotherapy services to more cancer patients [1] - Proton therapy is particularly suitable for lung cancer, liver cancer, pancreatic cancer, and is especially beneficial for pediatric tumors, offering better organ protection and higher patient satisfaction [1] - The center aims for significant breakthroughs by 2026, with plans to enhance its comprehensive cancer treatment capabilities [1] Group 2 - The imported proton therapy system at the Hefei Ion Medical Center is operating well, and a domestically developed proton therapy system is set to enter clinical trials soon [2] - The team is developing new proton therapy technologies, including spatially fractionated radiotherapy and the Bruce method, with plans for ultra-short treatment courses [2] - The center aims to become a leading regional medical center for proton therapy technology in China, with a focus on making high-precision proton therapy more accessible and affordable for patients [2]

Core Viewpoint - The Shenzhen Proton Therapy Center has officially opened, marking the first integrated medical, research, and teaching facility for proton therapy in South China, providing advanced cancer treatment services [1][2]. Group 1: Facility Overview - The center covers a total area of 35,000 square meters and is equipped with 5 treatment rooms and 300 beds, utilizing the IBA Proteus PLUS proton therapy system [1]. - Over 70% of cancer patients require radiotherapy, which traditionally damages surrounding healthy tissues; proton therapy minimizes this damage through its unique "Bragg Peak" effect [1][2]. Group 2: Clinical Trials and Patient Experience - The Shenzhen Proton Therapy Center has begun recruiting for clinical trials, with the first patient, referred to as Zhang, reporting minimal side effects from the treatment [2]. - The center aims to address the issue of local patients needing to travel for advanced cancer treatment, filling a significant gap in Shenzhen's healthcare offerings [2]. Group 3: Strategic Importance - The launch of the center is expected to enhance the overall treatment capabilities of Shenzhen hospitals and promote integrated development between medical institutions in Beijing and Shenzhen [3]. - The center is positioned to provide international-level precision radiotherapy services, potentially extending its influence to the Guangdong-Hong Kong-Macao Greater Bay Area and Southeast Asia, reinforcing Shenzhen's status as a key cancer treatment hub in southern China [3].

Core Viewpoint - Proton therapy has shown significant effectiveness in treating head and neck tumors, providing hope for patients who have faced challenges with traditional treatments [1][3][4] Group 1: Patient Success Stories - A patient named Sun experienced a near-complete disappearance of her nasal rhabdomyosarcoma after undergoing 30 sessions of proton therapy, alleviating her symptoms significantly [1] - Another patient, Mr. Chen, benefited from proton therapy for recurrent nasopharyngeal cancer, with significant tumor reduction observed after treatment [3] - Ms. Li, suffering from sinonasal neuroendocrine carcinoma, saw her tumor shrink from 7 cm to 2 cm after proton therapy, with substantial improvement in her quality of life [3] Group 2: Advantages of Proton Therapy - Proton therapy offers precise targeting of tumors, effectively killing cancer cells while minimizing damage to surrounding healthy tissues, leading to lower side effects compared to traditional radiation therapy [4] - The National Comprehensive Cancer Network (NCCN) has recognized proton therapy as a standard treatment method for head and neck cancers [4] Group 3: Institutional Background - Guangzhou Taihe Hospital's proton center is supported by renowned institutions like MD Anderson Cancer Center and Mayo Clinic, featuring advanced technology such as the Varian ProBeam proton therapy system [4] - The center has seen a growing number of consultations and treatments, with a peak of over 50 patients treated in a single day, covering various cancer types including nasopharyngeal, esophageal, lung, breast, and pancreatic cancers [4]